SwansonM.CookR.: Drugs, Chemicals and Blood Dyscrasias, Drug Intelligence Publications, Inc., Hamilton, Illinois, 1977, p. 129.
2.
BalodimosM. C.Camerini-DavalosR. A.MarbleA.: Nine Years Experience with Tolbutamide in the Treatment of Diabetes, Metab. Clin. Exp.15: 957–970 (Nov.) 1966.
3.
PrettyH. M.GosselinG.ColpronG.LongL. A.: Agranulocytosis: A Report of 30 Cases, Can. Med. Assoc. J.93: 1058–1064 (Nov.) 1965.
4.
PisciottaA. V.: Agranulocytosis Induced by Certain Phenothiazine Derivatives, J. Am. Med. Assoc.208: 1862–1868 (June) 1969.
5.
HoffmanG. C.HewlettJ. S.GarzonF. L.: A Drug Specific Leukoagglutinin in a Fatal Case of Agranulocytosis Due to Chlorpromazine, J. Clin. Pathol.16: 232–235 (May) 1963.
6.
LitvakR.KaelblingR.: Agranulocytosis, Leukopenia, and Psychotropic Drugs, Arch. Gen. Psychiatry24: 265–276 (Mar.) 1971.
7.
DenberH. C.: An Unusual Case of Chlorpromazine Agranulocytosis, Dis. Nerv. Syst.31 (suppl.): 134–139 (Nov.) 1970.